This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Branding Remove Genotype Remove In-Vitro Related Topics
Reagent Gene Editing Pharma Companies Genomics Genome Vaccine Vaccination Medicine Life Science Genetics More Related Topics >
article thumbnail

Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern

The Pharma Data

MARCH 16, 2022

To support customers performing human genotyping, TIB Molbiol provides custom-made LightSNiP assays for SNP analysis. Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, 3 and Delta. 2, as well as other mutations, present in the novel B.1.1.529

In-Vitro 52
In-Vitro Genotype Reagent Protein 52
article thumbnail

Nine new industry collaborations driving drug discovery forward

Drug Discovery World

MAY 29, 2024

By combining Closed Loop Medicine’s proprietary Software-as-a-Medical Device (SaMD) dose optimisation technology and Pharmanovia’s established medicine brands, the companies aim to support patients and healthcare professionals. We see a great need for a vaccine against EBV.” Sartorius has been working with NVIDIA since 2020.

Drugs 52
Drugs Gene Editing Life Science Genome 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024